I was wondering the same thing. Maybe the expectat
Post# of 36537
"The company’s subsidiary Olaregen launched Excellagen, which is FDA cleared for wound management, selling out the first commercial lot in less than a month."
What is the size of the first commercial lot and what are they selling for?
Quote:
Maybe I'm missing something, but won't (nearly) doubling the number of shares make getting to the minimum share price for up-listing (nearly) twice as hard?